Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience.

Authors

Laurie S ConklinFollow
Patrick J. Hanley, George Washington UniversityFollow
Jacques Galipeau
John Barrett
Catherine M. Bollard, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

4-19-2017

Journal

Cytotherapy

DOI

10.1016/j.jcyt.2017.03.006

APA Citation

Conklin, L., Hanley, P. J., Galipeau, J., Barrett, J., & Bollard, C. M. (2017). Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience.. Cytotherapy, (). http://dx.doi.org/10.1016/j.jcyt.2017.03.006

Peer Reviewed

1